Dr Elisa Bertoja

Dr Elisa BertojaTel: 020 3447 3343
Fax: 020 3447 9604
Email: elisa.bertoja@uclh.nhs.uk

Specialities:
Anaesthesia and Perioperative Medicine, Theatres

Professional background

I have been working as anaesthetist in several European countries, including Germany, Italy and UK. Upon completion of my anaesthetic training I took a year long fellowship in Cardiac Anaesthesia at the Heart Hospital followed by a Clinical Research fellowship in Hepatobiliary-liver transplant anaesthesia at the Royal Free Hospital.

I joined UCLH as Consultant in Jan 2008.

On top of my NHS commitments I am also Mentor to the London Deanery mentoring scheme for doctors and I am part of an international medical forum which offers expertise to trainees who want to pursue an Out Of Program Experience (OOPE)

Publications

Bertoja E, James KMH, Rolles K, Mallet SV, Preoperative HB[lt]10.5g/dL is a predictive factor for Red-Blood cell transfusion during Liver transplantation. Should this group receive preoperative Erythropoetin? Liver Transpl. 2008 Jul;14(7):S12.

James, K. M. H.; Bertoja,E; O'Beirne, J.; Mallett, S. V. Use of Thromboelastography Platelet Mapping(TM) (Haemoscope Corp.) to monitor anticoagulation therapy in a patient with Budd-Chiari syndrome: P74. Transfusion Alternatives in Transfusion Medicine. 10 Suppl. 1:46-47, April 2008.

“Heart disease in the surgical patient”, by Simon J. Howell, Chris Pepper, Donat R. Spahn Ch 13: Adult Congenital Heart Disease and the Surgical Patient, Barnard MJ, Bertoja E

Gattinoni L,Vagginelli F, Taccone P, Carlesso E, Bertoja E Sepsis: state of the art. Minerva Anestesiol. 2003 Jun;69(6):539-54, 554-61.

MD thesis on “Tight Glycemic control in septic patients”. Pilot study aimed at identifying the effects of tight glycaemic control on inflammatory and coagulation pathways in septic patients.

MD thesis on “Multi Organ Dysfunction Syndrome in liver transplantation: the role of the new liver”. I evaluated incidence of MODS and its impact on mortality in 92 orthotopic liver transplants. The primary end point was to identify predictive MODS risk factors correlated to the function of the new liver.

GMC/GDC number: 6073634